US Patent 10400028 Therapeutic variant alpha-2-macroglobulin compositions
Patent 10400028 was granted and assigned to Cytonics Corporation on September, 2019 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
November 20, 2015
0
Date of Patent
September 3, 2019
0
Patent Applicant
Patent Application Number
15528387
0
Patent Inventor Names
Shawn Robert Browning
0
John David Laughlin
0
Lewis Hanna
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10400028 Therapeutic variant alpha-2-macroglobulin compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
